Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 40,107 shares at $16.68 ($660K) on 2022-10-20, disclosed to the SEC on 2022-10-24.
Open-market sale of $660k ANTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.68 | 7,262 | $121K | 18.4% |
| 2 | $16.68 | 7,262 | $121K | 18.4% |
| 3 | $17.15 | 31 | $532 | 0.1% |
| 4 | $16.29 | 11,601 | $189K | 28.6% |
| 5 | $16.29 | 11,601 | $189K | 28.6% |
| 6 | $16.69 | 2,350 |
| $39K |
| 5.9% |
| Total | $16.46 avg | 40,107 | $660K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |